Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Recombinant Antibody

Anti-VIP Antibody (L108/92)

Catalog #:   RHB93602 Specific References (50) DATASHEET
Host species: Mouse
Isotype: IgG2a, kappa
Applications: IHC, WB
Overview

Catalog No.

RHB93602

Host species

Mouse

Isotype

IgG2a, kappa

Clonality

Monoclonal

Applications

IHC, WB

Target

Vasoactive intestinal polypeptide, Peptide histidine valine 42, VIP, Peptide histidine methioninamide 27, VIP peptides

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

L108/92

Note

For research use only.

Data Image
References

Sensory neurons regulate stimulus-dependent humoral immunity in mouse models of bacterial infection and asthma., PMID:39414787

Profile of cross-reactivity to common pollen allergens in Northwest China based on component resolved diagnosis., PMID:39424620

Single-cell transcriptome profiling identifies the activation of type I interferon signaling in ossified posterior longitudinal ligament., PMID:39441507

Interpreting epidemiologic distribution of total and specific IgE levels for food allergy in Southern China from 2004 to 2023: understanding the mechanisms and focusing on prevention., PMID:39482634

Recaticimab as Add-On Therapy to Statins for Nonfamilial Hypercholesterolemia: The Randomized, Phase 3 REMAIN-2 Trial., PMID:39505412

Accuracy of prostigmin tests in the diagnosis of myasthenia gravis: a meta-analysis., PMID:39544787

A humanized neutralizing antibody protects against human adenovirus type 7 infection in humanized desmoglein-2 and CD46 double-receptor transgenic mice., PMID:39548554

Co-targeting TMEM16A with a novel monoclonal antibody and EGFR with Cetuximab inhibits the growth and metastasis of esophageal squamous cell carcinoma., PMID:39563381

Validation and modification of renal risk score for prediction of long-term kidney survival in patients with MPO-ANCA-associated glomerulonephritis., PMID:39576457

Expert Consensus on the Diagnosis and Treatment of FGFR Gene-Altered Solid Tumors., PMID:39583123

Rubella antibody levels in the healthy Chinese population: a meta-analysis., PMID:39600703

Jingfang Granules alleviates the lipid peroxidation induced ferroptosis in rheumatoid arthritis rats by regulating gut microbiota and metabolism of short chain fatty acids., PMID:39608616

Diagnostic Efficacy of 11 SARS-CoV-2 Serological Assays for COVID-19: A Meta-Analysis and Adjusted Indirect Comparison of Diagnostic Test Accuracy., PMID:39698931

Association between depression and anxiety disorders with euthyroid Hashimoto's thyroiditis: A systematic review and meta-analysis., PMID:39717384

Immunization with OPN5 increased seasonal degradation of reproductive activity in Magang ganders., PMID:39754930

Nanobody-based indirect competitive ELISA for the detection of aflatoxin M1 in dairy products., PMID:39755714

Comparison of the clinicopathological characteristics of children with anti-neutrophil cytoplasmic antibody-associated vasculitis with/without infection at diagnosis., PMID:39762790

Distribution and neurochemical characterisation of neurons containing neuregulin 1 in the enteric nervous system within the porcine small intestine., PMID:39776680

Efficacy and safety of camrelizumab for the treatment of cervical cancer: a systematic review and meta-analysis., PMID:39777331

A phase Ia study of a novel anti-HER2 antibody-drug conjugate GQ1001 in patients with previously treated HER2 positive advanced solid tumors., PMID:39789619

A broadly neutralizing antibody against the SARS-CoV-2 Omicron sub-variants BA.1, BA.2, BA.2.12.1, BA.4, and BA.5., PMID:39800731

Efficacy, durability and safety of faricimab for patients with neovascular age-related macular degeneration: 48-week results from the phase 3 LUCERNE China subpopulation., PMID:39818248

Anti-GluK2 antibody-positive autoimmune encephalitis concurrent with multiple myeloma: a case report., PMID:39833741

A biodegradable magnesium alloy promotes subperiosteal osteogenesis via interleukin-10-dependent macrophage immunomodulation., PMID:39862617

Recombinant XBB.1.5 boosters induce robust neutralization against KP.2- and KP.3-included JN.1 sublineages., PMID:39870636

Efficacy and safety of neoadjuvant immunotherapy combined with chemotherapy for stage II-IVa esophageal cancer: a network meta-analysis., PMID:39871293

Preclinical evaluation of zirconium-89 labeled anti-Trop2 antibody-drug conjugate (Trodelvy) for imaging in gastric cancer and triple-negative breast cancer., PMID:39878898

The anti-PD-L1/CTLA-4 bispecific antibody KN046 plus lenvatinib in advanced unresectable or metastatic hepatocellular carcinoma: a phase II trial., PMID:39920148

Previous treatment decreases efficacy of pralsetinib in RET fusion-positive non-small-cell lung cancer., PMID:39926433

TIGIT expression in extrahepatic cholangiocarcinoma and its impact on CD8 + T cell exhaustion: implications for immunotherapy., PMID:39939322

Non-invasive assessment of HER2 expression in patients with urothelial carcinoma using [68Ga]Ga-HER2 affibody PET/CT imaging: preliminary clinical findings., PMID:39951137

Induction chemotherapy followed by camrelizumab plus apatinib and chemotherapy as first-line treatment for extensive-stage small-cell lung cancer: a multicenter, single-arm trial., PMID:39962074

Omics data integration analysis identified new biological insights into chronic antibody-mediated rejection (CAMR)., PMID:39979925

Comparative efficacy and safety of pyrotinib plus trastuzumab versus trastuzumab plus pertuzumab and trastuzumab monotherapy in neoadjuvant treatment of HER2-positive breast cancer: A systematic review and meta-analysis., PMID:39986012

Identification and Verification of the Driver Genes for the Formation and Development of Intracranial Aneurysms., PMID:39987975

New LFA-1 inhibitor Orientin reduces angiotensin II-induced vascular remodeling., PMID:39993698

Efficacy and safety of ongericimab in Chinese patients with heterozygous familial hypercholesterolemia: A randomized, double-blind, placebo-controlled phase 3 trial., PMID:39999660

Is ADC a rising star in solid tumor? An umbrella review of systematic reviews and meta-analyses., PMID:40021960

[Acquired factor Ⅴ inhibitor induced by surgical trauma complicated with fatal hemorrhage: a case report and literature review]., PMID:40032336

Efficacy and safety of sintilimab plus bevacizumab and CAPOX as first-line treatment for patients with RAS-mutant, microsatellite stable, metastatic colorectal cancer., PMID:40055652

Simplifying ANCA-associated vasculitis classification with ANCA specificity: a retrospective analysis., PMID:40100609

Duck plague virus UL47 gene affects the release and cell-to-cell spread of the virus and its deletion strains can provide strong protection for ducks., PMID:40158279

Evaluation of tumorous LCP1 and ADPGK as predictive biomarker for immune-related adverse events in bone and soft tissue sarcomas treated with anti-PD-1 and anti-PD-L1 antibodies., PMID:40189514

B-cell epitope peptide immunotherapy alleviates chitin-binding protein-induced type 2 airway inflammation in a Blomia tropicalis-murine model., PMID:40205365

Comparative efficacy and acceptability of novel biologics in the treatment of myasthenia gravis: systematic review and network meta-analysis of randomized trials., PMID:40346603

The protective efficacy of inactivated vaccine against hemorrhagic fever with renal syndrome: A meta-analysis., PMID:40388733

Clinical benefit of continuation of PD-1 inhibitors after progression on first-line chemoimmunotherapy in metastatic gastric cancer and biomarker exploration., PMID:40413463

miR-196b strictly regulates and reliably predicts the response to cetuximab in colorectal cancer., PMID:40414859

An efficient bivalent vaccine against duck Tembusu and duck plague viruses based on ribosomal skipping of DHAV-1 2A1 and abundant expression of DPV protein., PMID:40424885

Active Immunization Against Inhibin Impaired Spermatogenesis, Plasma Luteinizing Hormone, Pituitary Prolactin mRNA, and Hypothalamic Vasoactive Intestinal Peptide mRNA Expressions in Yangzhou Ganders., PMID:40431506

Datasheet

Document Download

Anti-VIP Antibody (L108/92).pdf

 

$ 328
Product specifications
100 μg 328 1 mg 1640

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-VIP Antibody (L108/92) [RHB93602]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only